The influenza therapeutics market is witnessing steady expansion as seasonal outbreaks, pandemic preparedness initiatives, and advancements in antiviral drug development continue to shape global healthcare priorities. According to industry estimates, the Influenza Therapeutics Market size is projected to grow from US$ 6.95 billion in 2025 to US$ 10.10 billion by 2034, registering a CAGR of...